MICHELLE LAPIDUS: Open Payments
NPI 1962508457 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,315 in 77 payments from 13 companies in 2025. Trend: 2023 $1,151 · 2024 $826 · 2025 $1,315
Food & beverage: $1,216Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $254 |
| PFIZER INC. | 17 | $216 |
| GENZYME CORPORATION | 12 | $175 |
| Novartis Pharmaceuticals Corporation | 10 | $165 |
| Regeneron Healthcare Solutions, Inc. | 5 | $144 |
| LEO Pharma Inc. | 5 | $79 |
| Amgen Inc. | 3 | $68 |
| UCB, Inc. | 3 | $58 |
| E.R. Squibb & Sons, L.L.C. | 3 | $45 |
| ABBVIE INC. | 2 | $43 |
Products named: DUPIXENT, TREMFYA, CIBINQO, COSENTYX, OTEZLA, Bimzelx, ADBRY, Sotyktu.
Industry payments across OK — which companies pay providers there.
